1. Home
  2. KOSS vs GBIO Comparison

KOSS vs GBIO Comparison

Compare KOSS & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KOSS
  • GBIO
  • Stock Information
  • Founded
  • KOSS 1953
  • GBIO 2016
  • Country
  • KOSS United States
  • GBIO United States
  • Employees
  • KOSS N/A
  • GBIO N/A
  • Industry
  • KOSS Consumer Electronics/Appliances
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • KOSS Consumer Staples
  • GBIO Health Care
  • Exchange
  • KOSS Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • KOSS 68.4M
  • GBIO 64.8M
  • IPO Year
  • KOSS N/A
  • GBIO 2020
  • Fundamental
  • Price
  • KOSS $6.62
  • GBIO $0.95
  • Analyst Decision
  • KOSS
  • GBIO Strong Buy
  • Analyst Count
  • KOSS 0
  • GBIO 2
  • Target Price
  • KOSS N/A
  • GBIO $6.50
  • AVG Volume (30 Days)
  • KOSS 148.4K
  • GBIO 749.9K
  • Earning Date
  • KOSS 01-30-2025
  • GBIO 03-05-2025
  • Dividend Yield
  • KOSS N/A
  • GBIO N/A
  • EPS Growth
  • KOSS N/A
  • GBIO N/A
  • EPS
  • KOSS N/A
  • GBIO N/A
  • Revenue
  • KOSS $12,092,999.00
  • GBIO $18,582,000.00
  • Revenue This Year
  • KOSS N/A
  • GBIO $212.74
  • Revenue Next Year
  • KOSS N/A
  • GBIO N/A
  • P/E Ratio
  • KOSS N/A
  • GBIO N/A
  • Revenue Growth
  • KOSS N/A
  • GBIO 514.08
  • 52 Week Low
  • KOSS $2.27
  • GBIO $0.75
  • 52 Week High
  • KOSS $18.73
  • GBIO $4.65
  • Technical
  • Relative Strength Index (RSI)
  • KOSS 38.21
  • GBIO 35.95
  • Support Level
  • KOSS $6.58
  • GBIO $0.86
  • Resistance Level
  • KOSS $7.27
  • GBIO $1.01
  • Average True Range (ATR)
  • KOSS 0.45
  • GBIO 0.12
  • MACD
  • KOSS -0.14
  • GBIO 0.01
  • Stochastic Oscillator
  • KOSS 3.48
  • GBIO 25.13

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: